UBS Group
TLSA icon

UBS Group’s Tiziana Life Sciences TLSA Stock Holding History

UBS Group’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Sell
95,700
-9,518
-9% -$13.5K ﹤0.01% 6950
2025
Q4 		$157K Buy
105,218
+81,588
+345% +$147K ﹤0.01% 6696
2025
Q3 		$51K Buy
23,630
+19,341
+451% +$35.8K ﹤0.01% 7548
2025
Q2 		$6.78K Sell
4,289
-610
-12% -$815 ﹤0.01% 9062
2025
Q1 		$5.29K Hold
4,899
– – ﹤0.01% 9013
2024
Q4 		$3.41K Buy
4,899
+4,289
+703% +$3.97K ﹤0.01% 8884
2024
Q3 		$586 Sell
610
-51,007
-99% -$51.5K ﹤0.01% 8877
2024
Q2 		$47.4K Buy
51,617
+19,763
+62% +$14.4K ﹤0.01% 6730
2024
Q1 		$14.5K Buy
31,854
+3,295
+12% +$1.73K ﹤0.01% 7068
2023
Q4 		$16K Buy
28,559
+27,849
+3,922% +$17.6K ﹤0.01% 7236
2023
Q3 		$469 Buy
710
+90
+15% +$62 ﹤0.01% 8475
2023
Q2 		$422 Sell
620
-5,592
-90% -$4.73K ﹤0.01% 8243
2023
Q1 		$6.78K Sell
6,212
-13,544
-69% -$8.86K ﹤0.01% 7884
2022
Q4 		$11.9K Sell
19,756
-1,987
-9% -$1.32K ﹤0.01% 8347
2022
Q3 		$16K Buy
21,743
+16,313
+300% +$12.3K ﹤0.01% 7707
2022
Q2 		$4K Buy
5,430
+4,557
+522% +$3.92K ﹤0.01% 9132
2022
Q1 		$1K Sell
873
-1,789
-67% -$1.58K ﹤0.01% 9929
2021
Q4 		$3K Sell
2,662
-705
-21% -$934 ﹤0.01% 9694
2021
Q3 		$5K Buy
3,367
+2,089
+163% +$3.86K ﹤0.01% 8558
2021
Q2 		$3K Buy
+1,278
New +$3.16K ﹤0.01% 8840
2020
Q4 		– Sell
-1,401
Closed -$5K – 8758
2020
Q3 		$5K Buy
+1,401
New +$5.45K ﹤0.01% 7339
2019
Q2 		– Sell
-7,552
Closed -$9K – 8157
2019
Q1 		$9K Sell
7,552
-3,499
-32% -$4.32K ﹤0.01% 6889
2018
Q4 		$16K Buy
+11,051
New +$17.9K ﹤0.01% 6952

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's TLSA Position: Q1 2026 in Review

UBS Group reduced its Tiziana Life Sciences (TLSA) stake by 9% in Q1 2026, selling an estimated $13.5K and leaving 95,700 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #6950.

UBS Group first reported a position in TLSA in Q4 2018 and has held it in 23 quarters since. The position peaked at $157K in Q4 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • UBS Group held 95,700 shares of Tiziana Life Sciences worth $112K as of Q1 2026.
  • UBS Group sold 9,518 Tiziana Life Sciences shares in Q1 2026, an estimated $13.5K.
  • Tiziana Life Sciences made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6950 holding.
  • UBS Group first reported a position in Tiziana Life Sciences in Q4 2018 and has held it in 23 quarters since.
  • UBS Group's Tiziana Life Sciences position peaked at $157K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.